Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools.
Gonzalez-Galarza FF, McCabe A, Santos EJMD, Jones J, Takeshita L, Ortega-Rivera ND, Cid-Pavon GMD, Ramsbottom K, Ghattaoraya G, Alfirevic A, Middleton D, Jones AR. · 2020
Read Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. by Gonzalez-Galarza FF, McCabe A, Santos EJMD, Jones J, Takeshita L, Ortega-Rivera ND, Cid-Pavon GMD, Ramsbottom K, Ghattaoraya G, Alfirevic A, Middleton D, Jones AR. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7145554.txt.
Introduction
Gonzalez-Galarza and co-authors update the Allele Frequency Net Database, which stores immune gene frequencies for populations worldwide, in Nucleic Acids Research. The database covers HLA genes, killer-cell receptors, and related immune polymorphisms, among the most variable regions of the human genome. It now holds more than 1,600 populations drawn from over 10 million healthy people.
New features include a gold, silver, and bronze quality grading so users can filter data by reliability, open genotype downloads, and a desktop tool that eases submissions. A section on HLA links to adverse drug reactions has grown as well. The resource serves transplant matching research, disease association studies, and population genetics.
Catalog record
| CREATOR | Gonzalez-Galarza FF, McCabe A, Santos EJMD, Jones J, Takeshita L, Ortega-Rivera ND, Cid-Pavon GMD, Ramsbottom K, Ghattaoraya G, Alfirevic A, Middleton D, Jones AR. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
By Faviel F Gonzalez-Galarza, Antony McCabe, Eduardo J Melo dos Santos, James Jones, Louise Takeshita, Nestor D Ortega-Rivera, Glenda M Del Cid-Pavon, Kerry Ramsbottom, Gurpreet Ghattaoraya, Ana Alfirevic, Derek Middleton, Andrew R Jones Published in: Nucleic Acids Research DOI: 10.1093/nar/gkz1029 ABSTRACT Abstract The Allele Frequency Net Database (AFND, www.allelefrequencies.net) provides the scientific community with a freely available repository for the storage of frequency data (alleles, genes, haplotypes and genotypes) related to human leukocyte antigens (HLA), killer-cell immunoglobulin-like receptors (KIR), major histocompatibility complex Class I chain related genes (MIC) and a number of cytokine gene polymorphisms in worldwide populations. In the last five years, AFND has become more popular in terms of clinical and scientific usage, with a recent increase in genotyping data as a necessary component of Short Population Report article submissions to another scientific journal. In addition, we have developed a user-friendly desktop application for HLA and KIR genotype/population data submissions. We have also focused on classification of existing and new data into ‘gold–silver–bronze’ criteria, allowing users to filter and query depending on their needs. Moreover, we have also continued to expand other features, for example focussed on HLA associations with adverse drug reactions. At present, AFND contains >1600 populations from >10 million healthy individuals, making AFND a valuable resource for the analysis of some of the most polymorphic regions in the human genome. INTRODUCTION The Allele Frequency Net Database (AFND) was originally designed to provide a freely available resource for the storage of frequency data on the polymorphisms of several immune related genes, including the human leukocyte antigens (HLA) system, killer-cell immunoglobulin-like receptors (KIR), major histocompatibility complex class I chain-related genes (MIC), and a number of cytokine gene polymorphisms (1). These loci, which are known to be among the most polymorphic regions in humans, play important roles in the immune system response. Different research areas have investigated these genomic regions due to their importance in donor-recipient matching in solid organ and stem cell transplantation outcome (2,3), response to various infectious diseases or susceptibility to the development of autoimmune diseases (4,5). In the last decade, there has been a substantial increase in research demonstrating that individuals carrying particular HLA alleles have a greater or lesser risk of developing immune-mediated adverse responses to particular drugs. As such, there has been growing interest in the field of pharmacogenetics research and clinical practice to understand global distributions of HLA alleles for profiling risk (6,7), which can be assisted by healthy populations in AFND. In the last five years, we have also started to capture case and control frequencies (and further statistics) from studies, to help understand HLA-adverse drug reactions (8). HLA population data, sourced from AFND also often underpins anthropology studies (9–11), as well as in silico analyses for vaccine development based on epitope prediction (12–14), among many other applications. There are currently >23 000 alleles that have been reported at the IMGT/HLA database (Release 3.37.0, July 2019) for HLA, and nearly 1000 alleles in the IPD-KIR database (Release 2.8.0, November 2018) for KIR (15,16). The vast majority of frequency records available in AFND (∼90%) corresponds to eight routinely-typed loci HLA-A, -B, -C, -DRB1, -DQB1, -DPA1 and -DPB1, although not all populations have been typed for all these loci. Moreover, there has been a recent increase in the number of populations genotyped for KIR and their corresponding HLA-ligands, which are also broadly analysed in disease association studies and transplantation. The first release of AFND in 2003 consisted of only a few sections and frequencies of HLA alleles/allelic lineages. However, in the last 17 years, many more tools have been incorporated into the database, producing a new release in 2011 and an update in 2015, both published in Nucleic Acid Research database issues (17,18). Over the past three years, nearly 100 000 different users from 186 countries have accessed the database. In this article, we describe an update of the available data sets, new developments for data submission and data sharing, as well as introducing a ‘gold–silver–bronze’ (GSB) criteria on data quality. DESCRIPTION OF AFND AND SOURCES OF DATA Database content The AFND website collects data from four main sources: (i) data from peer-reviewed publications, (ii) data from populations that are analysed at International HLA and Immunogenetics Workshops (IHWSs), (iii) submissions from individual laboratories across the world, and, more recently, (iv) short publication reports (SPR) in collaboration with the Human Immunology journal (19,20), as shown in Figure 1A. As of September 2019, we have compiled information on >1600 healthy populations from >10 million people. The HLA section contains the majority of the submissions with 1228 populations, followed by KIR 256, MIC 64 and 124 populations analysed for cytokine gene polymorphisms (Table 1). Currently, population data sets from 141 countries are included within AFND, with the highest coverage in Europe (396 populations), followed by North America (256 populations), South Asia (249 populations) and South and Central America (232 populations). In this database, users are able to browse for allele, gene, genotype or haplotype frequencies for HLA, KIR, MIC and cytokines, depending on their availability. [Figure: Overview of the main features in AFND. (A) Data sets are sourced from short population reports or direct AFND user submissions, both using the upload tool, from International HLA and Immunogenetics Workshops and from other peer reviewed publications, with allele and gene nomenclature synchronized with IMGT/HLA; (B) data undergo curation, including classification into gold–silver–bronze quality, and are stored under the different sections of the database; (C) a variety of query and custom-built visualization tools allow users to explore the different data sets.] [Table: Frequency data sets by polymorphic region at AFND, figures as of September 2019] Other databases AFND is currently hosting other resources, beyond data on healthy individuals. The database for HLA adverse drug reactions (HLA-ADR, http://allelefrequencies.net/hla-adr/) comprises nearly 2000 records from more than 100 studies, covering 46 drugs/drug-classes mainly compiled from literature searches. HLA-ADR allows users to query by drug, disease, locus, allele and so on, returning all the recorded data from case-control studies, including P-values for significant (and in some cases non-significant) associations. In addition, the KIR and Disease Database (KDDB, http://allelefrequencies.net/diseases/) captures results from disease association studies in KIR with ∼1500 records from more than 270 studies, including auto-immune disorders, infectious disease, cancer and pregnancy-related complications for which studies have demonstrated that the profile of KIR alleles, genes or haplotypes carried by an individual can affect risk. HLA-ADR and KDDB databases have been thoroughly described in two previous publications (8,21). Both HLA-ADR and KDDB can be queried and filtered in various ways, enabling users to assemble data sets for meta-analyses amongst other uses. Tools and searching mechanisms AFND contains a set of different systems to analyse data, as well as searching mechanisms for browsing frequency and genotype raw data. A list of the different tools is shown in Table 2. Despite the number of tools provided in AFND, according to our statistics, healthy population-related searches are among the most popular surveys in AFND with ‘HLA allele frequency search’ covering 27% of the hits in the website, followed by ‘HLA haplotype frequency search’ with 22% from a total of 221k visits over the last three years. [Table: Overview of the most popular searches and tools available